Purinergic receptors in airway hydration

Biochem Pharmacol. 2021 May:187:114387. doi: 10.1016/j.bcp.2020.114387. Epub 2021 Jan 5.

Abstract

Airway epithelial purinergic receptors control key components of the mucociliary clearance (MCC), the dominant component of pulmonary host defense. In healthy airways, the periciliary liquid (PCL) is optimally hydrated, thus acting as an efficient lubricant layer over which the mucus layer moves by ciliary force. When the hydration of the airway surface decreases, the mucus becomes hyperconcentrated, the PCL collapses, and the "thickened" mucus layer adheres to cell surfaces, causing plaque/plug formation. Mucus accumulation is a major contributing factor to the progression of chronic obstructive lung diseases such as cystic fibrosis (CF) and chronic bronchitis (CB). Mucus hydration is regulated by finely tuned mechanisms of luminal Cl- secretion and Na+ absorption with concomitant osmotically driven water flow. These activities are regulated by airway surface liquid (ASL) concentrations of adenosine and ATP, acting on airway epithelial A2B and P2Y2 receptors, respectively. The goal of this article is to provide an overview of our understanding of the role of purinergic receptors in the regulation of airway epithelial ion/fluid transport and the mechanisms of nucleotide release and metabolic activities that contribute to airway surface hydration in healthy and chronically obstructed airways.

Keywords: ATP hydrolysis; Airway epithelia; Airway hydration; Nucleotide release; Purinergic receptors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Humans
  • Lung / cytology
  • Lung / drug effects
  • Lung / metabolism
  • Lung Diseases / drug therapy
  • Lung Diseases / metabolism
  • Mucociliary Clearance / drug effects
  • Mucociliary Clearance / physiology*
  • Mucus / drug effects
  • Mucus / metabolism*
  • Purinergic Agonists / administration & dosage
  • Purinergic Antagonists / administration & dosage
  • Receptors, Purinergic / metabolism*
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / metabolism*

Substances

  • Purinergic Agonists
  • Purinergic Antagonists
  • Receptors, Purinergic
  • Adenosine Triphosphate